Between September 1984 and April 1987 a total of 150 patients underwent Nd-YAG laser iridotomy procedures at the Bristol Eye Hospital. Forty of these patients (27%) were treated for acute angle closure glaucoma (AACG), and three of them (7%) suffered recurrent AACG. Sixteen patients who had been treated for AACG have been challenged by a pharmacological provocative test introduced by Mapstone, with a total of 23 eyes being tested. A negative result was obtained in all cases. Provocative testing is recommended to help identify those at risk of recurrent AACG.
No takes yet. Share an insight, caveat, or question.
Gray et al. (1989) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: